Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz.

MLA

Crespan, Emmanuele, et al. “Drug Resistance Mutations in the Nucleotide Binding Pocket of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Differentially Affect the Phosphorolysis-Dependent Primer Unblocking Activity in the Presence of Stavudine and Zidovudine and Its Inhibition by Efavirenz.” Antimicrobial Agents and Chemotherapy, vol. 49, no. 1, Jan. 2005, pp. 342–49. EBSCOhost, https://doi.org/10.1128/AAC.49.1.342-349.2005.

APA

Crespan, E., Locatelli, G. A., Cancio, R., Hübscher, U., Spadari, S., & Maga, G. (2005). Drug resistance mutations in the nucleotide binding pocket of human immunodeficiency virus type 1 reverse transcriptase differentially affect the phosphorolysis-dependent primer unblocking activity in the presence of stavudine and zidovudine and its inhibition by efavirenz. Antimicrobial Agents and Chemotherapy, 49(1), 342–349. https://doi.org/10.1128/AAC.49.1.342-349.2005

Chicago

Crespan, Emmanuele, Giada A Locatelli, Reynel Cancio, Ulrich Hübscher, Silvio Spadari, and Giovanni Maga. 2005. “Drug Resistance Mutations in the Nucleotide Binding Pocket of Human Immunodeficiency Virus Type 1 Reverse Transcriptase Differentially Affect the Phosphorolysis-Dependent Primer Unblocking Activity in the Presence of Stavudine and Zidovudine and Its Inhibition by Efavirenz.” Antimicrobial Agents and Chemotherapy 49 (1): 342–49. doi:10.1128/AAC.49.1.342-349.2005.